Akebia Therapeutics, Inc 10-K for FY2021
Akebia Therapeutics, Inc. (AKBA)
10-K
2022-03-01
For: 2021-12-31
View Original
Added on
April 11, 2026
About this 10-K
Akebia Therapeutics, Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $213.58M
- down 27.7% from $295.31M a year earlier
- Net loss
- $282.84M
- compared with a net loss of $383.46M a year earlier
- Diluted EPS
- -$1.70
- compared with -$2.77 a year earlier